1. IMPACT OF REGULATORY DECISIONS AFTER PHASE III CLINICAL TRIALS RELATING TO ONCOLOGY DRUGS ON PHARMACEUTICAL STOCK RETURNS Open Access Author: Curotto, Andrew James Title: IMPACT OF REGULATORY DECISIONS AFTER PHASE III CLINICAL TRIALS RELATING TO ONCOLOGY DRUGS ON PHARMACEUTICAL STOCK RETURNS Area of Honors: Finance Keywords: pharmaceuticalevent studyfinanceclinical trialsstock returns File: Download A._Curotto_Thesis_Final.pdf Thesis Supervisors: Dr. Brian Spangler Davis, Thesis SupervisorDr. Brian Spangler Davis, Thesis Honors AdvisorProfessor Christoph Hinkelmann, Faculty Reader
2. Clinically Irrelevant Concentrations of Kinase Inhibitors Contribute to Failure of Drug Repurposing Efforts in Clinical Trials: a Meta-Analysis Open Access Author: Shah, Anushka Title: Clinically Irrelevant Concentrations of Kinase Inhibitors Contribute to Failure of Drug Repurposing Efforts in Clinical Trials: a Meta-Analysis Area of Honors: Biology Keywords: clinical trialsrepurposingcancerkinase inhibitorsmeta-analysisbiologyin vitrodrug concentrations File: Download Shah_SHCThesis.pdf Thesis Supervisors: Justin R Pritchard, Thesis SupervisorRichard W Ordway, Thesis Honors Advisor